Newport 2012 Publications

Reports from the 7th International Workshop on Waldenström’s Macroglobulinemia; August 23-26, 2012; Newport, Rhode Island, as published in Clinical Lymphoma, Myeloma & Leukemia, April 2013:

Proceedings of the Seventh International Workshop on Waldenstrom Macroglobulinemia

Immunoglobulin M Monoclonal Gammopathy of Undetermined Significance and Smoldering Waldenstrom Macroglobulinemia

Survival in Monoclonal Gammopathy of Undetermined Significance and Waldenstrom Macroglobulinemia

Familial Predisposition to Monoclonal Gammopathies: Deviations in B-Cell Biology

Etiology of Waldenstrom Macroglobulinemia: Genetic Factors and Immune-related Conditions

Genomic Abnormalities of Waldenstrom Macroglobulinemia and Related Low-Grade B-Cell Lymphomas

Genomic Studies Have Identified Multiple Mechanisms of Genetic Changes in Waldenstrom Macroglobulinemia

microRNA Aberrations in Waldenstrom Macroglobulinemia

Microarray Demonstrates Different Gene Expression Profiling Signatures Between Waldenstrom Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance

Immunoglobulin M Concentration in Waldenstrom Macroglobulinemia: Correlation With Bone Marrow B Cells and Plasma Cells

Intraclonal Heterogeneity in Concomitant Monoclonal Lymphocyte and Plasma Cell Populations: Combining Flow Cytometric Cell Sorting With Molecular Monoclonality Profiling

The Bone Marrow Microenvironment in Waldenstrom Macroglobulinemia

Targeting the Toll-like Receptor/Interleukin 1 Receptor Pathway in Human Diseases: Rational Design of MyD88 Inhibitors

Primary Therapy of Waldenstrom Macroglobulinemia With Nucleoside Analogue–Based Therapy

Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenstrom’s Macroglobulinemia

Proteasome Inhibitor Therapy for Waldenstrom’s Macroglobulinemia

Role of Plasmapheresis in Waldenstrom’s Macroglobulinemia

Patients With Waldenstrom Macroglobulinemia Commonly Present With Iron Deficiency and Those With Severely Depressed Transferrin Saturation Levels Show Response to Parenteral Iron Administration

Diagnostic Challenges of Amyloidosis in Waldenstrom Macroglobulinemia

Challenges With Serum Protein Electrophoresis in Assessing Progression and Clinical Response in Patients With Waldenstrom Macroglobulinemia

Comparative Response Assessment by Serum Immunoglobulin M M-Protein and Total Serum Immunoglobulin M After Treatment of Patients With Waldenstrom Macroglobulinemia